SCHEMBL5083344

SCHEMBL5083344

CCCCC1(CO)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 1.00
PKM P14618 1/20 1.00
CYP2C19 P33261 2/20 0.61
ELANE P08246 4/20 0.59
LMNA P02545 4/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
HTT P42858 2/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 4/20 0.57
NPSR1 Q6W5P4 2/20 0.55
GPR55 Q9Y2T6 2/20 0.55
CNR1 P21554 1/20 0.55
CYP3A4 P08684 2/20 0.43
RAB9A P51151 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
MAPK1 P28482 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4731087 0.87 KDM4E (0.77) KDM4EPKMCYP2C19ELANELMNA
SCHEMBL11338190 0.84 KDM4E (0.72) KDM4EPKMCYP2C19ELANELMNA
SCHEMBL13777324 0.82 KDM4E (0.69) KDM4EPKMCYP2C19ELANELMNA
SCHEMBL5956271 0.81 KDM4E (0.68) KDM4EPKMCYP2C19ELANELMNA
SCHEMBL11337366 0.80 KDM4E (0.67) KDM4EPKMCYP2C19ELANELMNA
SCHEMBL11597911 0.79 LMNA (0.67) KDM4EPKMCYP2C19ELANELMNA
SCHEMBL17131137 0.79 KDM4E (0.65) KDM4EPKMCYP2C19ELANELMNA
SCHEMBL11538498 0.79 KDM4E (0.65) KDM4EPKMCYP2C19ELANELMNA
SCHEMBL2760391 0.79 CYP2C19 (0.80) KDM4EPKMCYP2C19ELANELMNA
SCHEMBL17112254 0.79 KDM4E (0.64) KDM4EPKMCYP2C19ELANELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154954-A1 Combinations and use of selected pharmaceutically active compounds ALTANA PHARMA AG (DE) 2006-07-13 US claimed
EP-1599175-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA Pharma AG (DE) 2005-11-30 EP claimed
WO-2005074930-A1 PHARMACEUTICAL COMBINATIONS OF (S) -PANTOPRAZOLE WITH NSAID OR CORTICOSTEROIDS ALTANA PHARMA AG (DE) 2005-08-18 WO claimed
US-20040242597-A1 Combination NYCOMED GMBH (DE) 2004-12-02 US claimed
WO-2004071391-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA PHARMA AG (DE) 2004-08-26 WO claimed
EP-1429807-A2 COMBINATION OF A NSAID AND A PDE-4 INHIBITOR ALTANA Pharma AG (DE) 2004-06-23 EP claimed
WO-2003024489-A2 COMBINATION OF A NSAID AND A PDE-4 INHIBITOR ALTANA PHARMA AG (DE) 2003-03-27 WO claimed
US-8242146-B2 Administering ROFLUMILAS and DICLOFENAC; antiinflammatory agents NYCOMED GMBH (DE) 2012-08-14 US disclosed
US-20080255209-A1 Combination of a NSAID and a PDE-4 inhibitor NYCOMED GMBH (DE) 2008-10-16 US disclosed
US-20060154954-A1 Combinations and use of selected pharmaceutically active compounds ALTANA PHARMA AG (DE) 2006-07-13 US disclosed
EP-1599175-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA Pharma AG (DE) 2005-11-30 EP disclosed
WO-2005074930-A1 PHARMACEUTICAL COMBINATIONS OF (S) -PANTOPRAZOLE WITH NSAID OR CORTICOSTEROIDS ALTANA PHARMA AG (DE) 2005-08-18 WO disclosed
US-20040242597-A1 Combination NYCOMED GMBH (DE) 2004-12-02 US disclosed
WO-2004071391-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA PHARMA AG (DE) 2004-08-26 WO disclosed
US-4273873-A BONDING SYNTHETIC FIBRINOLYTIC COMPOUND OR ENZYME UNITIKA LTD. (JP) 1981-06-16 US disclosed